Tech Company Financing Transactions
Modulus Discovery Funding Round
Modulus Discovery, based in Cambridge, secured $25.5 million from Dai Ichi Life Insurance, Fast Track Initiative and JAFCO.
Transaction Overview
Company Name
Announced On
5/13/2020
Transaction Type
Venture Equity
Amount
$25,500,000
Round
Series B
Investors
Proceeds Purpose
Modulus will use the proceeds to further its unique small-molecule lead programs in oncology and inflammatory / immune disorders and expand its portfolio of early programs and collaborations including those with its strategic partner, PeptiDream, Inc.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Modulus Discovery, Inc., is a preclinical-stage technology-driven drug discovery firm with offices in Tokyo and Boston. The company is pursuing its proprietary portfolio of small-molecule discovery programs and collaborations through integration of its unique core biology insights, cutting-edge discovery platform, and scalable networked operations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roy Kimura
Chief Operating Officer
Kazuki Ohno
Chief Scientific Officer
Yoh Terada
Vice President
Taisuke Takahashi
VP - Bus. Development
Takahito Nakahara
Browse more venture capital transactions:
Prev: 5/13/2020: Lilt venture capital transaction
Next: 5/13/2020: LexCheck venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC transactions on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs